Katie Adams

The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and BJC Health, much of that investment could be wasted. During a panel this week at HFMA’s annual conference, they argued that no amount of sophisticated tech can overcome a broken, antiquated data foundation.

The healthcare affordability crisis in the U.S. has quietly become a trust crisis, with a growing share of Americans walking away from care altogether. Industry leaders say the fix requires something the system has never really done: starting with the patient.

The healthcare affordability crisis in the U.S. has quietly become a trust crisis, with a growing share of Americans walking away from care altogether.

MultiCare CFO James Lee said decades of government underpayment have pushed U.S. healthcare to a breaking point. He thinks the nation is headed toward a two-tier system — one for patients with commercial coverage, and another for those covered through CMS.

Verily is testing wastewater across World Cup host cities for pathogens like RSV, measles and norovirus, aiming to spot outbreaks five to seven days before they show up in clinics.

AI hasn't solved all the problems plaguing healthcare's revenue cycle — but R1's Lee Kupferman says that it is getting closer, one gray area at a time.

AI hasn't solved all the problems plaguing healthcare's revenue cycle — but R1's Lee Kupferman says that it is getting closer, one gray area at a time.

A recent JAMA editorial from two radiologists argues that elective whole-body MRI scan companies are misleading consumers about the benefits of said scans. The radiologists argue the MRIs are more likely to trigger harmful downstream procedures than they are to save lives. Not surprisingly, the three most prominent companies offering these scans denied the charge.

Mayo Clinic is deploying AI across its revenue cycle operations, but revenue cycle chair Todd Manion said he's skeptical that these functions will be fully automated anytime soon.

Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program.